Jewasity · Aug 20, 2026
Jewasity — photo status
Moderna’s stock nearly doubled after its personalized mRNA cancer vaccine scored a major Phase 3 trial win. Developed with Merck, the custom-built shot significantly delayed melanoma from returning and is now being tested against several other cancers.
More from Jewasity
- JewasityNov 4, 2026 · WOW! Security camera footage from Santiago, Chile shows a lo
- JewasityNov 4, 2026 · Elon Musk predicts AI will be smarter than all humans combin
- JewasityNov 4, 2026 · A giant poster of Trump, Netanyahu, Vance and Witkoff was se
- JewasityNov 4, 2026 · Netanyahu says he wants a broad Likud-led government with hi
- JewasityNov 4, 2026 · Florida Gov. Ron DeSantis says Republicans in Congress hurt
- JewasityNov 4, 2026 · President Trump now agrees the Iran war was a factor in Repu
